PML and acute promyelocytic leukemia: The first cancer for which differentiation therapy was demonstrated as a viable approach was acute promyelocytic leukemia (APL), a sub‐type of AML commonly driven by the t(15;17) chromosomal translocation encoding the PML‐RARα fusion protein.